Orphan Drug
Drug Use Review Documents
PDL Status Values
Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the
Non-Preferred Drugs in Select PDL Classes prior authorization criteria.
New drugs will be listed as N until reviewed by the P&T Committee and are subject to the
New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.
To request a Prior Authorization, please use this form.
NDC | Brand Name | Generic Name | Form | Strength | PDL Status |
Rebate | Current Drug Use Criteria |
---|---|---|---|---|---|---|---|
64764013501 | ADZYNMA | ADAMTS13, recombinant-krhn | KIT | 1,500 (+/-) unit range | Y | PA Document | |
64764014505 | ADZYNMA | ADAMTS13, recombinant-krhn | KIT | 1,500 (+/-) unit range | Y | PA Document | |
64764013001 | ADZYNMA | ADAMTS13, recombinant-krhn | KIT | 500 (+/-) unit range | Y | PA Document | |
64764014005 | ADZYNMA | ADAMTS13, recombinant-krhn | KIT | 500 (+/-) unit range | Y | PA Document | |
00078117519 | VIJOICE | alpelisib | GRAN PACK | 50 mg | Y | PA Document | |
00078117551 | VIJOICE | alpelisib | GRAN PACK | 50 mg | Y | PA Document | |
00078102884 | VIJOICE | alpelisib | TABLET | 125 mg | Y | PA Document | |
00078103502 | VIJOICE | alpelisib | TABLET | 250 mg/day (200 mg x 1 and 50 mg x 1) | Y | PA Document | |
00078103561 | VIJOICE | alpelisib | TABLET | 250 mg/day (200 mg x 1 and 50 mg x 1) | Y | PA Document | |
00078102151 | VIJOICE | alpelisib | TABLET | 50 mg | Y | PA Document | |
00078102184 | VIJOICE | alpelisib | TABLET | 50 mg | Y | PA Document | |
72542012401 | MIPLYFFA | arimoclomol citrate | CAPSULE | 124 mg | Y | PA Document | |
72542014701 | MIPLYFFA | arimoclomol citrate | CAPSULE | 47 mg | Y | PA Document | |
72542016201 | MIPLYFFA | arimoclomol citrate | CAPSULE | 62 mg | Y | PA Document | |
72542019301 | MIPLYFFA | arimoclomol citrate | CAPSULE | 93 mg | Y | PA Document | |
83222020001 | LENMELDY | atidarsagene autotemcel | PLAST. BAG | 2 x 10exp6 to 11.8 x 10exp6 cell/mL | Y | PA Document | |
73556016801 | TAVNEOS | avacopan | CAPSULE | 10 mg | Y | PA Document | |
73556016802 | TAVNEOS | avacopan | CAPSULE | 10 mg | Y | PA Document | |
50881002311 | NIKTIMVO | axatilimab-csfr | VIAL | 22 mg/0.44 mL | Y | PA Document | |
50881003412 | NIKTIMVO | axatilimab-csfr | VIAL | 9 mg/0.18 mL | Y | PA Document | |
79802020030 | REZUROCK | belumosudil mesylate | TABLET | 200 mg | N | Y | PA Document |
82194050101 | VYJUVEK | beremagene geperpavec-svdt | GEL (ML) | 5 x 10exp9 PFU/2.5 mL | Y | PA Document | |
82194051002 | VYJUVEK | beremagene geperpavec-svdt | GEL (ML) | 5 x 10exp9 PFU/2.5 mL | Y | PA Document | |
10122031001 | FILSUVEZ | birch bark extract | GEL (GRAM) | 10 % | Y | PA Document | |
10122031002 | FILSUVEZ | birch bark extract | GEL (GRAM) | 10 % | Y | PA Document | |
76431031001 | FILSUVEZ | birch bark extract | GEL (GRAM) | 10 % | Y | PA Document | |
42747010201 | CRYSVITA | burosumab-twza | VIAL | 10 mg/mL | Y | PA Document | |
42747020301 | CRYSVITA | burosumab-twza | VIAL | 20 mg/mL | Y | PA Document | |
42747030401 | CRYSVITA | burosumab-twza | VIAL | 30 mg/mL | Y | PA Document | |
68135081102 | BRINEURA | cerliponase alfa | KIT | 300 mg/10 mL (150 mg/5 mL X 2) | Y | PA Document | |
68135050000 | BRINEURA | cerliponase alfa | VIAL | 150 mg/5 mL | Y | PA Document | |
68974087640 | CHENODAL | chenodiol | TABLET | 250 mg | Y | PA Document | |
79378031090 | CTEXLI | chenodiol | TABLET | 250 mg | Y | PA Document | |
70370510001 | CRENESSITY | crinecerfont | CAPSULE | 100 mg | Y | PA Document | |
70370502501 | CRENESSITY | crinecerfont | CAPSULE | 25 mg | Y | PA Document | |
70370505001 | CRENESSITY | crinecerfont | CAPSULE | 50 mg | Y | PA Document | |
70370525001 | CRENESSITY | crinecerfont | SOLUTION | 50 mg/mL | Y | PA Document | |
50242011501 | PIASKY | crovalimab-akkz | VIAL | 340 mg/2 mL | Y | PA Document | |
25682004392 | VOYDEYA | danicopan | TABLET | 100 mg | Y | PA Document | |
25682004692 | VOYDEYA | danicopan | TABLET | 150 mg (50 mg x 1 and 100 mg x 1) | Y | PA Document | |
25682000101 | SOLIRIS | eculizumab | VIAL | 300 mg/30 mL | Y | PA Document | |
51759020813 | EPYSQLI | eculizumab-aagh | VIAL | 300 mg/30 mL | N | Y | PA Document |
55513018001 | BKEMV | eculizumab-aeeb | VIAL | 300 mg/30 mL | N | Y | PA Document |
52856060101 | KEBILIDI | eladocagene exuparvovec-tneq | VIAL | 2.8 x 10exp11 vector genomes/0.5 mL | Y | PA Document | |
52856060111 | KEBILIDI | eladocagene exuparvovec-tneq | VIAL | 2.8 x 10exp11 vector genomes/0.5 mL | Y | PA Document | |
15054008001 | IQIRVO | elafibranor | TABLET | 80 mg | Y | PA Document | |
10122050201 | REVCOVI | elapegademase-lvlr | VIAL | 2.4 mg/1.5 mL (1.6 mg/mL) | Y | PA Document | |
73554211101 | SKYSONA | elivaldogene autotemcel | PLAST. BAG | 4 x 10exp6 to 30 x 10exp6 cell/mL | Y | PA Document | |
42358029501 | NULIBRY | fosdenopterin hydrobromide | VIAL | 9.5 mg | Y | PA Document | |
71336100101 | GIVLAARI | givosiran sodium | VIAL | 189 mg/mL | Y | PA Document | |
75987015001 | UPLIZNA | inebilizumab-cdon | VIAL | 100 mg/10 mL (10 mg/mL) | Y | PA Document | |
75987015003 | UPLIZNA | inebilizumab-cdon | VIAL | 100 mg/10 mL (10 mg/mL) | Y | PA Document | |
00078118920 | FABHALTA | iptacopan HCl | CAPSULE | 200 mg | N | Y | PA Document |
71274017060 | JOENJA | leniolisib phosphate | TABLET | 70 mg | Y | PA Document | |
83853010101 | AQNEURSA | levacetylleucine | GRAN PACK | 1 gram | Y | PA Document | |
72065000301 | RECORLEV | levoketoconazole | TABLET | 150 mg | Y | PA Document | |
42358045030 | ZOKINVY | lonafarnib | CAPSULE | 50 mg | Y | PA Document | |
73079005030 | ZOKINVY | lonafarnib | CAPSULE | 50 mg | Y | PA Document | |
42358047530 | ZOKINVY | lonafarnib | CAPSULE | 75 mg | Y | PA Document | |
73079007530 | ZOKINVY | lonafarnib | CAPSULE | 75 mg | Y | PA Document | |
71336100201 | OXLUMO | lumasiran sodium | VIAL | 94.5 mg/0.5 mL | Y | PA Document | |
59572071101 | REBLOZYL | luspatercept-aamt | VIAL | 25 mg | Y | PA Document | |
59572077501 | REBLOZYL | luspatercept-aamt | VIAL | 75 mg | Y | PA Document | |
79378011101 | LIVMARLI | maralixibat chloride | SOLUTION | 19 mg/mL | Y | PA Document | |
79378011001 | LIVMARLI | maralixibat chloride | SOLUTION | 9.5 mg/mL | Y | PA Document | |
79378021030 | LIVMARLI | maralixibat chloride | TABLET | 10 mg | Y | PA Document | |
79378021530 | LIVMARLI | maralixibat chloride | TABLET | 15 mg | Y | PA Document | |
79378022030 | LIVMARLI | maralixibat chloride | TABLET | 20 mg | Y | PA Document | |
79378023030 | LIVMARLI | maralixibat chloride | TABLET | 30 mg | Y | PA Document | |
73625011311 | CAMZYOS | mavacamten | CAPSULE | 10 mg | Y | PA Document | |
73625011411 | CAMZYOS | mavacamten | CAPSULE | 15 mg | Y | PA Document | |
73625011111 | CAMZYOS | mavacamten | CAPSULE | 2.5 mg | Y | PA Document | |
73625011211 | CAMZYOS | mavacamten | CAPSULE | 5 mg | Y | PA Document | |
83296010012 | XOLREMDI | mavorixafor | CAPSULE | 100 mg | Y | PA Document | |
83296010060 | XOLREMDI | mavorixafor | CAPSULE | 100 mg | Y | PA Document | |
83296010090 | XOLREMDI | mavorixafor | CAPSULE | 100 mg | Y | PA Document | |
82448013042 | GOMEKLI | mirdametinib | CAPSULE | 1 mg | Y | PA Document | |
82448026042 | GOMEKLI | mirdametinib | CAPSULE | 2 mg | Y | PA Document | |
82448026084 | GOMEKLI | mirdametinib | CAPSULE | 2 mg | Y | PA Document | |
82448013442 | GOMEKLI | mirdametinib | TAB SUSP | 1 mg | Y | PA Document | |
82448013484 | GOMEKLI | mirdametinib | TAB SUSP | 1 mg | Y | PA Document | |
71334022512 | PYRUKYND | mitapivat sulfate | TAB DS PK | 20 mg (7)-5 mg (7) | Y | PA Document | |
71334023013 | PYRUKYND | mitapivat sulfate | TAB DS PK | 50 mg (7)-20 mg (7) | Y | PA Document | |
71334021007 | PYRUKYND | mitapivat sulfate | TABLET | 20 mg | Y | PA Document | |
71334021014 | PYRUKYND | mitapivat sulfate | TABLET | 20 mg | Y | PA Document | |
71334021020 | PYRUKYND | mitapivat sulfate | TABLET | 20 mg | Y | PA Document | |
71334020505 | PYRUKYND | mitapivat sulfate | TABLET | 5 mg | Y | PA Document | |
71334020507 | PYRUKYND | mitapivat sulfate | TABLET | 5 mg | Y | PA Document | |
71334020514 | PYRUKYND | mitapivat sulfate | TABLET | 5 mg | Y | PA Document | |
71334022011 | PYRUKYND | mitapivat sulfate | TABLET | 5 mg | Y | PA Document | |
71334021507 | PYRUKYND | mitapivat sulfate | TABLET | 50 mg | Y | PA Document | |
71334021514 | PYRUKYND | mitapivat sulfate | TABLET | 50 mg | Y | PA Document | |
71334021550 | PYRUKYND | mitapivat sulfate | TABLET | 50 mg | Y | PA Document | |
00169530708 | RIVFLOZA | nedosiran sodium | SYRINGE | 128 mg/0.8 mL | Y | PA Document | |
00169530610 | RIVFLOZA | nedosiran sodium | SYRINGE | 160 mg/mL | Y | PA Document | |
00169530801 | RIVFLOZA | nedosiran sodium | VIAL | 80 mg/0.5 mL (160 mg/mL) | Y | PA Document | |
57894080101 | IMAAVY | nipocalimab-aahu | VIAL | 1,200 mg/6.5 mL (185 mg/mL) | Y | PA Document | |
15054330401 | BYLVAY | odevixibat | CAPSULE | 1,200 mcg | Y | PA Document | |
74528012001 | BYLVAY | odevixibat | CAPSULE | 1,200 mcg | Y | PA Document | |
15054330201 | BYLVAY | odevixibat | CAPSULE | 400 mcg | Y | PA Document | |
74528004001 | BYLVAY | odevixibat | CAPSULE | 400 mcg | Y | PA Document | |
15054330101 | BYLVAY | odevixibat | PEL DSP CP | 200 mcg | Y | PA Document | |
74528002001 | BYLVAY | odevixibat | PEL DSP CP | 200 mcg | Y | PA Document | |
15054330301 | BYLVAY | odevixibat | PEL DSP CP | 600 mcg | Y | PA Document | |
74528006001 | BYLVAY | odevixibat | PEL DSP CP | 600 mcg | Y | PA Document | |
58468005001 | XENPOZYME | olipudase alfa-rpcp | VIAL | 20 mg | Y | PA Document | |
58468005101 | XENPOZYME | olipudase alfa-rpcp | VIAL | 4 mg | Y | PA Document | |
73362010001 | YORVIPATH | palopegteriparatide | PEN INJCTR | 168 mcg teriparatide/0.56 mL | Y | PA Document | |
73362010002 | YORVIPATH | palopegteriparatide | PEN INJCTR | 168 mcg teriparatide/0.56 mL | Y | PA Document | |
73362010003 | YORVIPATH | palopegteriparatide | PEN INJCTR | 168 mcg teriparatide/0.56 mL | Y | PA Document | |
73362010101 | YORVIPATH | palopegteriparatide | PEN INJCTR | 294 mcg teriparatide/0.98 mL | Y | PA Document | |
73362010102 | YORVIPATH | palopegteriparatide | PEN INJCTR | 294 mcg teriparatide/0.98 mL | Y | PA Document | |
73362010103 | YORVIPATH | palopegteriparatide | PEN INJCTR | 294 mcg teriparatide/0.98 mL | Y | PA Document | |
73362010201 | YORVIPATH | palopegteriparatide | PEN INJCTR | 420 mcg teriparatide/1.4 mL | Y | PA Document | |
73362010202 | YORVIPATH | palopegteriparatide | PEN INJCTR | 420 mcg teriparatide/1.4 mL | Y | PA Document | |
73362010203 | YORVIPATH | palopegteriparatide | PEN INJCTR | 420 mcg teriparatide/1.4 mL | Y | PA Document | |
15054001001 | SOHONOS | palovarotene | CAPSULE | 1 mg | Y | PA Document | |
15054001501 | SOHONOS | palovarotene | CAPSULE | 1.5 mg | Y | PA Document | |
15054010001 | SOHONOS | palovarotene | CAPSULE | 10 mg | Y | PA Document | |
15054002501 | SOHONOS | palovarotene | CAPSULE | 2.5 mg | Y | PA Document | |
15054005001 | SOHONOS | palovarotene | CAPSULE | 5 mg | Y | PA Document | |
73606001001 | EMPAVELI | pegcetacoplan | VIAL | 1,080 mg/20 mL (54 mg/mL) | Y | PA Document | |
70573009901 | RYPLAZIM | plasminogen, human-tvmh | VIAL | 68.8 mg | Y | PA Document | |
70573009902 | RYPLAZIM | plasminogen, human-tvmh | VIAL | 68.8 mg | Y | PA Document | |
61755001400 | VEOPOZ | pozelimab-bbfg | VIAL | 400 mg/2 mL (200 mg/mL) | Y | PA Document | |
61755001401 | VEOPOZ | pozelimab-bbfg | VIAL | 400 mg/2 mL (200 mg/mL) | Y | PA Document | |
25682002801 | ULTOMIRIS | ravulizumab-cwvz | VIAL | 1,100 mg/11 mL (100 mg/mL) | Y | PA Document | |
25682002501 | ULTOMIRIS | ravulizumab-cwvz | VIAL | 300 mg/3 mL (100 mg/mL) | Y | PA Document | |
73648011101 | RYONCIL | remestemcel-L-rknd | KIT | 6.68 x 10exp6 cell/mL (3.8 mL x 1) | Y | PA Document | |
73648011202 | RYONCIL | remestemcel-L-rknd | KIT | 6.68 x 10exp6 cell/mL (3.8 mL x 2) | Y | PA Document | |
73648011303 | RYONCIL | remestemcel-L-rknd | KIT | 6.68 x 10exp6 cell/mL (3.8 mL x 3) | Y | PA Document | |
73648011401 | RYONCIL | remestemcel-L-rknd | KIT | 6.68 x 10exp6 cell/mL (3.8 mL x 4) | Y | PA Document | |
73648011502 | RYONCIL | remestemcel-L-rknd | KIT | 6.68 x 10exp6 cell/mL (3.8 mL x 5) | Y | PA Document | |
73648011603 | RYONCIL | remestemcel-L-rknd | KIT | 6.68 x 10exp6 cell/mL (3.8 mL x 6) | Y | PA Document | |
73648011704 | RYONCIL | remestemcel-L-rknd | KIT | 6.68 x 10exp6 cell/mL (3.8 mL x 7) | Y | PA Document | |
73648011802 | RYONCIL | remestemcel-L-rknd | KIT | 6.68 x 10exp6 cell/mL (3.8 mL x 8) | Y | PA Document | |
73648015401 | RYONCIL | remestemcel-L-rknd | VIAL | 6.68 x 10exp6 cell/mL | Y | PA Document | |
73648015404 | RYONCIL | remestemcel-L-rknd | VIAL | 6.68 x 10exp6 cell/mL | Y | PA Document | |
70842024001 | REZZAYO | rezafungin acetate | VIAL | 200 mg | Y | PA Document | |
50474098079 | RYSTIGGO | rozanolixizumab-noli | VIAL | 280 mg/2 mL (140 mg/mL) | Y | PA Document | |
50474098183 | RYSTIGGO | rozanolixizumab-noli | VIAL | 420 mg/3 mL (140 mg/mL) | Y | PA Document | |
50474098284 | RYSTIGGO | rozanolixizumab-noli | VIAL | 560 mg/4 mL (140 mg/mL) | Y | PA Document | |
50474098386 | RYSTIGGO | rozanolixizumab-noli | VIAL | 840 mg/6 mL (140 mg/mL) | Y | PA Document | |
50242000701 | ENSPRYNG | satralizumab-mwge | SYRINGE | 120 mg/mL | Y | PA Document | |
61958330101 | LIVDELZI | seladelpar lysine | CAPSULE | 10 mg | Y | PA Document | |
73077001001 | PEDMARK | sodium thiosulfate | VIAL | 12.5 gram/100 mL (125 mg/mL) | Y | PA Document | |
80203034701 | ENJAYMO | sutimlimab-jome | VIAL | 1,100 mg/22 mL (50 mg/mL) | Y | PA Document | |
64406010901 | QALSODY | tofersen | VIAL | 100 mg/15 mL (6.7 mg/mL) | Y | PA Document | |
81802000108 | CUVRIOR | trientine tetrahydrochloride | TABLET | 300 mg | Y | PA Document | |
81802000172 | CUVRIOR | trientine tetrahydrochloride | TABLET | 300 mg | Y | PA Document | |
10122018001 | LAMZEDE | velmanase alfa-tycv | VIAL | 10 mg | Y | PA Document | |
10122018002 | LAMZEDE | velmanase alfa-tycv | VIAL | 10 mg | Y | PA Document | |
50474099080 | ZILBRYSQ | zilucoplan sodium | SYRINGE | 16.6 mg/0.416 mL | N | Y | PA Document |
50474099180 | ZILBRYSQ | zilucoplan sodium | SYRINGE | 23 mg/0.574 mL | N | Y | PA Document |
50474099280 | ZILBRYSQ | zilucoplan sodium | SYRINGE | 32.4 mg/0.81 mL | N | Y | PA Document |